Back to medications
Medication monograph

tralokinumab

Interleukin-13 (IL-13) AntagonistsImmunomodulatorsMonoclonal AntibodiesInterleukin-13 Antagonist

Clinical reference

Product monograph

ADBRY- tralokinumab-ldrm injection, solution

Brands & formulations

Family members

ADTRALZA

Marketed
150 MGSUBCUTANEOUSSOLUTION[ "tralokinumab" ]
Product monograph

ADTRALZA

Marketed
300 MGSUBCUTANEOUSSOLUTION[ "tralokinumab" ]
Product monograph

Classification

Chemical class
Interleukin-13 (IL-13) Antagonists
Clinical class
Immunomodulators, Monoclonal Antibodies
Banks class
Interleukin-13 Antagonist